Regulus Therapeutics (RGLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,590 | 23,829 | 24,290 | 60,445 | 31,087 |
| Marketable Securities | 37,249 | N/A | 14,932 | N/A | N/A |
| Receivables | N/A | N/A | N/A | N/A | 503 |
| TOTAL | $82,345 | $28,179 | $44,079 | $65,235 | $36,730 |
| Non-Current Assets | |||||
| PPE Net | 937 | 1,061 | 536 | 281 | 472 |
| Intangibles | 25 | 33 | 62 | 83 | 125 |
| Other Non-Current Assets | 874 | 1,477 | 2,039 | 2,855 | 277 |
| TOTAL | $1,836 | $2,571 | $2,637 | $3,219 | $874 |
| Total Assets | $84,181 | $30,750 | $46,716 | $68,454 | $37,604 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,334 | 4,511 | N/A | 4,652 |
| Accounts payable and accrued liabilities | 947 | 204 | 175 | 285 | 535 |
| Accrued Expenses | 5,403 | 4,591 | 4,418 | 3,647 | 3,421 |
| Other current liabilities | 1,149 | 2,379 | 2,553 | 1,295 | 2,970 |
| TOTAL | $7,499 | $8,508 | $11,657 | $5,227 | $11,578 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 4,673 | N/A |
| Other Non-Current Liabilities | 274 | 1,055 | 1,768 | 3,596 | 0 |
| TOTAL | $274 | $1,055 | $1,768 | $8,269 | $N/A |
| Total Liabilities | $7,773 | $9,563 | $13,425 | $13,496 | $11,578 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,243 | 65,465 | 16,840 | 14,597 | 7,250 |
| Common Shares | 66 | 20 | 17 | 15 | 67 |
| Retained earnings | -559,571 | -513,213 | -483,176 | -454,853 | -427,045 |
| Other shareholders' equity | 55 | 5 | -7 | 5 | 2 |
| TOTAL | $76,408 | $21,187 | $33,291 | $54,958 | $26,026 |
| Total Liabilities And Equity | $84,181 | $30,750 | $46,716 | $68,454 | $37,604 |